Open AccessExperimental studies on glycolytic enzyme inhibitory and antiglycation potential of Triphala
Author(s) -
Aditya Ganeshpurkar,
Sumeet Jain,
Sonam Agarwal
Publication year - 2015
Publication title -
ayu
Language(s) - English
Resource type - Journals
eISSN - 0976-9382
pISSN - 0974-8520
DOI - 10.4103/0974-8520.169000
Subject(s) - fructosamine , chemistry , alpha glucosidase , enzyme , glycation , glycolysis , traditional medicine , amylase , biochemistry , alpha amylase , pharmacology , diabetes mellitus , medicine , endocrinology , receptor
Imbalance in cellular metabolism of carbohydrates and lipids is observed in diabetes mellitus. Pancreatic α-amylase and α-glucosidases are responsible for the conversion of polysaccharides into glucose that enters in the blood stream. Triphala has shown antidiabetic effects (type 2) in human subjects. However, its effects on glycolytic enzymes and protein glycation have not been studied.